Qiagen creates 90 jobs; Molecular Insight talks to creditors;

 @FierceBiotech: Third Rock raising $400M venture fund for biotech "game-changers." Report | Follow @FierceBiotech

 @JohnCFierce: Judging 3 categories for the World Vaccines Congress awards. I have to say the level of innovation in vaccines today is extraordinary. | Follow @JohnCFierce

> Dutch diagnostics and assay company Qiagen said Thursday it plans to spend about $52 million to expand its North American headquarters in Germantown, adding 117,000 square feet of new manufacturing and office space to accommodate at least 90 new full-time jobs by 2015. Story

> Several months after it received permission to expand a toothpaste factory in Clifton, a British pharmaceutical company said it will leave the Passaic County town--costing 270 New Jerseyans their jobs. Report

> Molecular Insight Pharmaceuticals says it received a 30-day extension of its waiver agreement with its bond holders, sending its shares up as much as 6 percent in pre-market trade. Report

And Finally... Pfizer was voted as the best employer in Czech Republic in a ranking organized by consulting firm Hewitt Associates. Report

Suggested Articles

Pliant Therapeutics will use the proceeds to push its lead program through midstage trials in fibrotic liver and lung diseases.

Cancer biotech Novellus has struck a deal with Plexxikon for its early- to midstage BRAF-inhibiting hopeful PLX8394.

Chinook Therapeutics is set to merge with fallen Big Pharma darling Aduro Biotech to create a kidney disease player with $180 million in cash.